Abbott results beat on medical device boost, Exact deal hits forecast
April 16 (Reuters) - Abbott marginally beat Wall Street estimates for quarterly profit and revenue on Thursday, partially helped by its newly acquired cancer diagnostics business.
However, its shares were down 2% before the bell, after the company said its 2026 profit forecast will see... Read More.
